Drug Oncology

Bavencio

Payments companies reported to CMS as associated with Bavencio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$848Kassociated payments (2023-2025)

3,975clinicians with associated payments

7companies reporting

By year

2023 $841K

2024 $6,690

Payments reported as associated with Bavencio, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Hematology & Oncology $316K

Medical Oncology $163K

Family $153K

Internal Medicine $53K

Medical $43K

Nurse Practitioner $40K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Bavencio

These are the largest totals companies reported as associated with Bavencio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Amit Mehta	Cary, NC	Hematology & Oncology	$67,824.91
Stephanie Bradley-Miller	Chicago, IL	Family	$51,540.23
Alan Tan	Nashville, TN	Hematology & Oncology	$43,305.83
Lisa Adams	Honolulu, HI	Medical	$39,851.48
Lasherri Leathers	Charlotte, NC	Family	$36,708.11
Mohammadbagher Ziari	Corona, CA	Hematology & Oncology	$34,196.10
Devesh Pandya	Houston, TX	Hematology & Oncology	$30,451.54
Chad Pedersen	Watford City, ND	Medical Oncology	$28,415.67
Nancy Dawson	Washington, DC	Medical Oncology	$26,698.30
Marisol Rivera	Hollywood, FL	Family	$23,940.42

Prescribed Bavencio?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.